Gotham Asset Management’s Astrana Health ASTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-7,695
Closed -$312K 1536
2024
Q2
$312K Buy
7,695
+1,558
+25% +$61.8K ﹤0.01% 1216
2024
Q1
$258K Buy
+6,137
New +$239K ﹤0.01% 1225
2022
Q4
Sell
-14,108
Closed -$550K 1327
2022
Q3
$550K Sell
14,108
-8,984
-39% -$411K 0.02% 827
2022
Q2
$891K Sell
23,092
-15,257
-40% -$580K 0.03% 599
2022
Q1
$1.86M Buy
38,349
+1,266
+3% +$65.3K 0.06% 368
2021
Q4
$2.73M Buy
+37,083
New +$3.05M 0.09% 283

Other funds holding ASTH

Gotham Asset Management's ASTH Position: Q3 2024 in Review

Gotham Asset Management sold out of Astrana Health (ASTH) in Q3 2024, closing a stake of 7,695 shares — an estimated $312K sold.

Gotham Asset Management first reported a position in ASTH in Q4 2021 and held it in 6 quarters. The position peaked at $2.73M in Q4 2021. 189 funds tracked by Wall St. Rank hold ASTH as of Q3 2024.

  • Gotham Asset Management reported no remaining Astrana Health position as of Q3 2024 after selling out during the quarter.
  • Gotham Asset Management sold 7,695 Astrana Health shares in Q3 2024, an estimated $312K.
  • Gotham Asset Management first reported a position in Astrana Health in Q4 2021 and held it in 6 quarters.
  • Gotham Asset Management's Astrana Health position peaked at $2.73M in Q4 2021.
  • 189 funds tracked by Wall St. Rank held Astrana Health as of Q3 2024.

Based on Gotham Asset Management's 13F filing for Q3 2024, filed 14 Nov 2024.